• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Director Whitmore Bradford T bought $148,475 worth of shares (27,160 units at $5.47) (SEC Form 4)

    5/15/25 4:25:37 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous
    Get the next $ULBI alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    WHITMORE BRADFORD T

    (Last) (First) (Middle)
    5215 OLD ORCHARD ROAD
    SUITE 620

    (Street)
    SKOKIE IL 60077

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    ULTRALIFE CORP [ ULBI ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/13/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/13/2025 P 8,957 A $5.3983(1) 1,029,884 I(2) By Whitmore Holdings, LLC
    Common Stock 05/14/2025 P 16,063 A $5.4715(3) 1,045,947 I(2) By Whitmore Holdings, LLC
    Common Stock 05/15/2025 P 2,140 A $5.7169(4) 1,048,087 I(2) By Whitmore Holdings, LLC
    Common Stock 205,915 D
    Common Stock 4,452,283 I(5) By SUNRAY I, LLC
    Common Stock 518,616 I(6) By Grace Brothers, LP
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.2572 to $5.58. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
    2. As manager of Whitmore Holdings, LLC (and trustee of Bradford Whitmore Trust, the sole member of Whitmore Holdings, LLC), Bradford T. Whitmore is the indirect beneficial owner of these shares.
    3. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.30 to $5.57. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
    4. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.7132 to $5.7198. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
    5. As manager of Sunray I, LLC, Bradford T. Whitmore is an indirect beneficial owner of 4,452,283 shares of Common Stock.
    6. As manager of Whitmore Holdings, LLC, which is the sole General Partner of Grace Brothers, LP, Bradford T. Whitmore is an indirect beneficial owner of 518,616 shares of Common Stock.
    Bradford T. Whitmore 05/15/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ULBI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ULBI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ULBI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Whitmore Bradford T bought $148,475 worth of shares (27,160 units at $5.47) (SEC Form 4)

      4 - ULTRALIFE CORP (0000875657) (Issuer)

      5/15/25 4:25:37 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Director Saeli Thomas Louis bought $27,200 worth of Common Stock; $.10 par value (5,000 units at $5.44), increasing direct ownership by 6% to 85,000 units (SEC Form 4)

      4 - ULTRALIFE CORP (0000875657) (Issuer)

      5/14/25 4:54:27 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Director Robert W. Shaw bought $21,960 worth of Common Stock; $.10 par value (4,000 units at $5.49), increasing direct ownership by 6% to 69,250 units (SEC Form 4)

      4 - ULTRALIFE CORP (0000875657) (Issuer)

      5/14/25 1:37:43 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous

    $ULBI
    SEC Filings

    See more
    • SEC Form 10-Q filed by Ultralife Corporation

      10-Q - ULTRALIFE CORP (0000875657) (Filer)

      5/12/25 4:38:55 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Ultralife Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - ULTRALIFE CORP (0000875657) (Filer)

      5/9/25 7:00:11 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Amendment: SEC Form 10-K/A filed by Ultralife Corporation

      10-K/A - ULTRALIFE CORP (0000875657) (Filer)

      4/28/25 4:51:00 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous

    $ULBI
    Leadership Updates

    Live Leadership Updates

    See more

    $ULBI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Ultralife Corporation Expands Leadership Team to Drive Rapid Growth Plans

      NEWARK, N.Y., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) today announced the appointment of Jeffrey Luke as Chief Marketing Officer and James Pope as Senior Vice President - Sales & Business Development, Battery & Energy Products, effective January 6, 2025. As Chief Marketing Officer, Jeff will be responsible for reframing our corporate and brand strategies, providing alignment and accountability throughout the global organization. He will collaborate closely with our sales and engineering teams to develop and execute effective go-to-market strategies, ensuring that Ultralife's products and solutions meet the evolving needs of our customers. Jeff brings over two

      1/6/25 7:00:00 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Ultralife Corporation Names Michael E. Manna President & CEO

      NEWARK, N.Y., Nov. 22, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of Ultralife Corporation ("Ultralife" or the "Company") (NASDAQ:ULBI) has appointed Michael E. Manna as the Company's President & CEO and as a member of the Board of Directors effective immediately to replace Michael D. Popielec who is leaving the Company. Mr. Popielec will remain with Ultralife as an employee for a sixty-day period ending January 20, 2023 in an advisory role to ensure a smooth leadership transition. In addition to his new role, Mike Manna will retain his leadership position for the Company's Battery & Energy Products segment which he held prior to his appointment as President & CEO. "Over the past twe

      11/22/22 4:30:00 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Ultralife Corporation Reports First Quarter Results

      NEWARK, N.Y., May 09, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the first quarter ended March 31, 2025 with the following highlights: Sales of $50.7 million compared to $41.9 million for the 2024 first quarter, including a 32.4% increase for Batteries & Energy Products and a 36.2% decrease in Communications Systems salesGross profit of $12.7 million, or 25.1% of revenue, compared to $11.5 million, or 27.4% of revenue, for the 2024 first quarterOperating income of $3.4 million, including one-time non-recurring costs and purchase accounting adjustments of $0.4 million, compared to $4.1 million for the 2024 first quarterGAAP EPS of $0.11 comp

      5/9/25 7:00:00 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Ultralife Corporation to Report First Quarter Results on May 9, 2025

      NEWARK, N.Y., April 29, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) will report its first quarter results for the period ended March 31, 2025 before the market opens on Friday, May 9, 2025. Ultralife's Management will also host an investor conference call and simultaneous webcast at 10:00 AM ET on May 9, 2025. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call: https://register-conf.media-server.com/register/BI00ee37974c5b4cbc86cd1d7ef099d998. This will e

      4/29/25 9:00:00 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Ultralife Corporation Reports Fourth Quarter Results

      Acquisition of Electrochem Completed and Integration Has Commenced                 NEWARK, N.Y., April 01, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:   ULBI) reported operating results for the fourth quarter and full year ended December 31, 2024 as follows: Fourth Quarter: Sales of $43.9 million compared to $44.5 million for the 2023 fourth quarter, including a 11.7% increase in Battery & Energy Products sales and a 55.1% decrease in Communications Systems salesGross profit of $10.6 million, or 24.2% of revenue, compared to $11.4 million, or 25.6% of revenue, for the 2023 fourth quarterOperating income of $1.5 million, including one-time costs and GAAP adjustments of

      4/1/25 7:00:00 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous

    $ULBI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Ultralife Corporation

      SC 13D/A - ULTRALIFE CORP (0000875657) (Subject)

      9/3/24 4:15:14 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form SC 13G filed by Ultralife Corporation

      SC 13G - ULTRALIFE CORP (0000875657) (Subject)

      2/14/24 1:50:40 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form SC 13G/A filed by Ultralife Corporation (Amendment)

      SC 13G/A - ULTRALIFE CORP (0000875657) (Subject)

      2/9/24 9:59:17 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous

    $ULBI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $ULBI
    Financials

    Live finance-specific insights

    See more

    $ULBI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Director Whitmore Bradford T bought $148,475 worth of shares (27,160 units at $5.47) (SEC Form 4)

      4 - ULTRALIFE CORP (0000875657) (Issuer)

      5/15/25 4:25:37 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Director Saeli Thomas Louis bought $27,200 worth of Common Stock; $.10 par value (5,000 units at $5.44), increasing direct ownership by 6% to 85,000 units (SEC Form 4)

      4 - ULTRALIFE CORP (0000875657) (Issuer)

      5/14/25 4:54:27 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Director Robert W. Shaw bought $21,960 worth of Common Stock; $.10 par value (4,000 units at $5.49), increasing direct ownership by 6% to 69,250 units (SEC Form 4)

      4 - ULTRALIFE CORP (0000875657) (Issuer)

      5/14/25 1:37:43 PM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Ultralife Corporation Reports First Quarter Results

      NEWARK, N.Y., May 09, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the first quarter ended March 31, 2025 with the following highlights: Sales of $50.7 million compared to $41.9 million for the 2024 first quarter, including a 32.4% increase for Batteries & Energy Products and a 36.2% decrease in Communications Systems salesGross profit of $12.7 million, or 25.1% of revenue, compared to $11.5 million, or 27.4% of revenue, for the 2024 first quarterOperating income of $3.4 million, including one-time non-recurring costs and purchase accounting adjustments of $0.4 million, compared to $4.1 million for the 2024 first quarterGAAP EPS of $0.11 comp

      5/9/25 7:00:00 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Ultralife Corporation to Report First Quarter Results on May 9, 2025

      NEWARK, N.Y., April 29, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) will report its first quarter results for the period ended March 31, 2025 before the market opens on Friday, May 9, 2025. Ultralife's Management will also host an investor conference call and simultaneous webcast at 10:00 AM ET on May 9, 2025. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call: https://register-conf.media-server.com/register/BI00ee37974c5b4cbc86cd1d7ef099d998. This will e

      4/29/25 9:00:00 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Ultralife Corporation Reports Fourth Quarter Results

      Acquisition of Electrochem Completed and Integration Has Commenced                 NEWARK, N.Y., April 01, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:   ULBI) reported operating results for the fourth quarter and full year ended December 31, 2024 as follows: Fourth Quarter: Sales of $43.9 million compared to $44.5 million for the 2023 fourth quarter, including a 11.7% increase in Battery & Energy Products sales and a 55.1% decrease in Communications Systems salesGross profit of $10.6 million, or 24.2% of revenue, compared to $11.4 million, or 25.6% of revenue, for the 2023 fourth quarterOperating income of $1.5 million, including one-time costs and GAAP adjustments of

      4/1/25 7:00:00 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • Benchmark initiated coverage on Ultralife with a new price target

      Benchmark initiated coverage of Ultralife with a rating of Buy and set a new price target of $12.00

      3/26/21 8:30:50 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous
    • The Benchmark Company initiated coverage on Ultralife with a new price target

      The Benchmark Company initiated coverage of Ultralife with a rating of Buy and set a new price target of $12.00

      3/26/21 7:38:12 AM ET
      $ULBI
      Industrial Machinery/Components
      Miscellaneous